Aytu Biopharma, Inc (AYTU) — SC 13D/A Filings
All SC 13D/A filings from Aytu Biopharma, Inc. Browse 1 SC 13D/A reports with AI-powered summaries and risk analysis.
SC 13D/A Filings (1)
-
Nantahala Capital Amends Aytu BioPharma Stake
— Jun 18, 2024 Risk: medium
Nantahala Capital Management, LLC, through its group members Daniel Mack and Wilmot B. Harkey, has amended its Schedule 13D filing regarding Aytu BioPharma, Inc
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX